secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longevity Health Holdings, Inc. (XAGE)
CIK:        0001842939
Form:       8-K
Filed at:   2023-08-14T23:59:59+00:00
Accession:  0001193125-23-211437
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 2.01, 3.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Carmell completes acquisition of Axolotl Biologix; $8M cash + $57M stock at closing, up to $75M earn-out
--------------------------------------------------------------------------------

- Closed merger with Axolotl on Aug 9, 2023; issued 3,845,337 common shares and 4,243 Series A preferred shares.
- Initial consideration: $8M cash (contingent on audited financials) and $57M in equity valued at $7.05/share VWAP.
- Up to $75M in milestone payments tied to revenue targets, contract execution, and clinical milestones.
- Company rebranded as Carmell Corporation targeting $100M FY24 revenue and a cosmeceutical launch by FY24.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842939/000119312523211437/0001193125-23-211437-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842939/000119312523211437/d512799d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-211437

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer